2: Combination casdatifan plus cabozantinib in previously treated patients with clear cell renal cell carcinoma: results from an expansion cohort of ARC-20 (NCT05536141)
2:卡达替凡联合卡博替尼治疗既往接受过治疗的透明细胞肾细胞癌患者:ARC-20 扩展队列的结果 (NCT05536141)
期刊:
影响因子:
doi:10.1101/2025.06.23.661183
Shaik, Abdul A; Panthagani, Praneetha; Liu, Xiaobo; Navarro-Turk, Stephany; Garza, Jeremy; Aguilera, Monica; Sanchez, Jordan; Gupta, Kushal; Hamood, Abdul; Reid, Ted W; Blough, Bruce; Pauli, Elliott; Bailoo, Jeremy D; Bergeson, Susan E; Barata, Pedro C; Rini, Brian; Choueri, Toni; Pal, Sumanta; Barthelemy, Philippe; Iacovelli, Roberto; McGregor, Bradley A; Albiges, Laurence; Molina-Cerrillo, Javier; Garmezy, Benjamin; Hauke, Ralph; Tejwani, Sheela; Basu, Arnab; Moon, Helen; Beckermann, Katy; Ornstein, Moshe; McKay, Rana; Lebedinsky, Claudia; Braendle, Edgar E; Motzer, Robert; Choueri, Toni; Ornstein, Moshe; Barata, Pedro C; Matrana, Marc; Merchan, Jaime; Gedye, Craig; Hwang, Clara; Kumar, Rohit; Lee, Jae Lyun; Guan, Yinghui; Ghasemi, Mohammad; Quadri, Syed; Negro, Chris; Chen, Jianfen; Foster, Paul; Warad, Deepti; McGregor, Bradley A; Rha, Sun Young; Drakaki, Alexandra